Vir Biotechnology Inc (VIR)
Fixed asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 74,205 | 86,180 | 1,580,470 | 1,087,070 | 76,368 |
| Property, plant and equipment | US$ in thousands | — | — | 188,166 | 130,054 | 17,946 |
| Fixed asset turnover | — | — | 8.40 | 8.36 | 4.26 |
December 31, 2024 calculation
Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $74,205K ÷ $—K
= —
The fixed asset turnover ratio for Vir Biotechnology Inc has shown a significant improvement over the years. It increased from 4.26 in December 31, 2020, to 8.36 in December 31, 2021, and further to 8.40 in December 31, 2022. This indicates that the company is generating more revenue relative to its investment in fixed assets, which is a positive sign of efficiency in asset utilization. The data for December 31, 2023 and December 31, 2024 is not available, so it is unclear how the ratio may have trended in those years. Overall, the increasing trend in fixed asset turnover suggests that Vir Biotechnology Inc is effectively using its fixed assets to drive revenue growth.
Peer comparison
Dec 31, 2024